The ASEAN Dx Initiative (ASEAN DxI) is a regional collaboration platform co-led by the Philippine Council for Health Research (PCHRD) and Singapore’s Diagnostics Development Hub (DxD Hub). It was launched in 2018 at the 18th ASEAN Ministerial Meeting on Science, Technology, and Innovation. We facilitate the co-development and adoption of healthcare diagnostics solutions for unmet clinical needs across ASEAN Member States (AMS).
Our objectives include:
ASEAN DxI is launched at the 18th ASEAN Ministerial Meeting on Science, Technology, and Innovation (AMMSTI-18).
Initiated in October, The ASEAN Sero-Surveillance Study for COVID-19 (ASSeSS) brought together experts from 6 ASEAN Member States (AMS) to conduct the first regional serology study on COVID.
Accelerating Diagnostics Access in ASEAN (ADAA) - The first post-COVID in-person regional roundtable aimed at leveraging insights and innovations gained during the pandemic and identifying needs in ASEAN countries to prepare for future pandemics.
ASEAN DxI organised and curated a lecture covering transformational innovation for preparedness and resilience under the Pandemic Preparedness and Health System Resistance Track at Temasek Foundation Pinnacle Series @ 7th World One Health Congress (2022).
PREPARE Diagnostics Co-op (i.e. DxD Hub), ASEAN DxI and Institute of High Performance Computing (IHPC) organised the first iteration of a series of four thematic workshops: Research, Engagements and Alliance for Diseases caused by Infections (READI).
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders. Get inspired by our #WomeninSTEM